InvestorsHub Logo
Followers 1
Posts 149
Boards Moderated 0
Alias Born 05/12/2016

Re: ash111 post# 3838

Wednesday, 09/21/2016 4:36:04 PM

Wednesday, September 21, 2016 4:36:04 PM

Post# of 8449
I was surprised to see that they started with a 27M patients with osteoarthritis as opposed to the 50M in Kitovs presentations. Also they had max market penetration at 2% where Kitov's presentation had higher numbers.

However it seemed to me that they were generous in listing the non-generic 2014 celebrex sales price